TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes of non-motor symptom scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of sleep quality scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes of Rapid-eye-movement Sleep Behavior Disorder scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: short-term post-operative sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy consumption (MET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PrAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mortality after brain tumor surgery
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Tinnitus Functional Index (TFI) Responders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical improvement in PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum humoral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Clinically Significant Change from Baseline in Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Working Memory Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inattentive Traits Self-Report
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of PDA Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain score on arrival to PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain score at discharge from PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth days to opioid initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth months to opioid initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth substance use severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Catastrophising Scale (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of returning to golf
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Timing of returning to golf
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Financial Toxicity PROFFIT financial score
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Change in Prothrombin time (PT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: inter-reader discordance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-averaged serum concentration over 28 days (Cavgd28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough serum concentration at steady-state (Cminss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geriatric oral health assessment index (GOHAI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oral Health Assessment Tool (OHAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral health impact profile (OHIP)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Meal satisfaction seven-item questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: feasibility and safety of RAPA-501
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occlusion rate of the aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Disease severity of inflammatory bowel disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Skin temperature change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Thermal Sensation change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Rating Scale (DRS) total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Elevated erythrocyte sedimentation rate (ESR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dupilumab-regulated transcriptome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dupilumab-regulated phosphoproteome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dupilumab-regulated secretome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perceptual Criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major non-fatal cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intervention effects on pain ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention effects on negative affect ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of patients willing to learn self-management of vaginal pessary
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heel-rise height during heel-rise work test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of TRP 8802
Endpoint domain: Adverse events/effects
Primary endpoint: 2-year central nervous system relapse rate
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of doxorubicin in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 16s DNA analysis in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sustained changes in Revised Fibromyalgia Impact Questionnaire (FIQR)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients switched based on risk perception
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of peri-implantitis
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative analgesia measured by FLACC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure success
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of in-hospital Major Adverse Cardiovascular Events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Young children's participation and environment measure (YC-PEM)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in HbA1c levels after 3 months treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in HbA1c levels equal to or more than 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratio of patients who reached the HbA1c target of equal to or below 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to resolution of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MTD or the best effective dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of AE, SAE, AESI
Endpoint domain: Adverse events/effects
Primary endpoint: Pulsatile Index (PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants able to wear the Garmin watch throughout remote PCIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post traumatic syndrome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of osteolysis around dental implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the number of HIV diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Proportion with ≥75 points decrease in IBS-SSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Level of Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Performance score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Alerness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hopelessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in wish to live
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression of liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Deep peroneal nerve motor distal latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Deep peroneal nerve sensory onset latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete pulmonary structural response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total direct non-medical costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Women's stress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with episodes or exacerbations of medical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with infections
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with kidney disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative level of Parathyroid hormone (PTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 68Ga-Fibroblast Activation Protein Inhibitor-04 Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pancreatic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Spontaneously Reported Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Deaths
Endpoint domain: Mortality/survival
Primary endpoint: Suicidality Assessment Using the Columbia Suicide Severity Rating Scale (C-SSRS) Score
Endpoint domain: Adverse events/effects
Primary endpoint: Phosphorylation of tyrosine residues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Tidal hyperinflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Stool microbiome analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sleep fragmentation at 1-month
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Symptoms of insomnia at 1-month
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Upper limb ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in left ventricular ejection fraction, end-diastolic volume or left ventricular mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of HIV-exposed infants receiving appropriate testing and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Reduction in Wound Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Ideal age at marriage
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Expected age at marriage
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Expected probability of undergoing social egg freezing
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in MY-ACDAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Posterior capsular opacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of Posterior capsular opacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of bimekizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia for cancer-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of GDF-15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum pain felt during LP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical events related to study participation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bone Mineral Density - DXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Bone Mineral Density - pQCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Microvascular blood volume (MBV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Self-Injury Urges
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline Hemoglobin A1c (HgA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skill assessment for physical examination of the abdomen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill assessment for physical examination of the heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evaluation of physical examination skills of the respiratory system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Flow Mediated Dilation (FMD) in brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sleep period time (SPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from sleep onset until final awakening (TST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early detection of postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Quality of life (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Forward slippage in static mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forward slippage in dynamic mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Predicted Trough Plasma Concentration (Cmin) of ATM and AVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of nirmatrelvir and ritonavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve to the End of the Dosing Period (AUC0-tau) of nirmatrelvir and ritonavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment Emergent Adverse Events (TEAEs) leading to discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Disease response to CD7/CD5 CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural course of PLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicide intent/risk
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of DLTs during the first cycle
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events characterized by type, frequency, severity, timing, seriousness and relationship to study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Foot ulcer healing status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot ulcer size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of foot ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Douleur Neuropathique 4 Questionnaire DN4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fatigue Severity Scale (FSS) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Total Lesion Symptom Scale (TLSS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Standardized total urea clearance index (Kt/V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of qPCR quantification of Staphylococcus aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of IDEAL Goals sessions received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: passive range of motion for the shoulder joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: modified Ashworth scale (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total number of DBT sessions used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of unscheduled/expedited DBT sessions required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequencies of factors leading to unscheduled/expedited DBT sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of anatomical retinal attachment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of fundus OCT and OCTA examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Immune Phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Movement Disorders Society - Unified Parkinson's Disease Rating Scale Section III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Changes of ALSFRS-R scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Mini Mental State Assessment test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brief screening of psychiatric concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of primary CMV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Energy intake as proportion of estimated requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge of physicians towards adolescent well care visits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes of physicians towards adolescent well-care visits
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants who achieved systemic lupus erythematosus remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Credibility of each component of the interprofessional intervention programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: All interventions are rated as > 70% acceptable
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Study participants adhere to their instructions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: General Nutrition Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Food and Nutrition Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep Diary
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Polysomnographic Recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological Attention Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: dorsal radioscaphoid translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain of the teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of EBV DNA in viral conjunctivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound contraction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ENDS cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Activity Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximally tolerated fraction dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to Preop Placement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average number of stools with a BSS score of 6 or 7 per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes